A Study to Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy Subjects

NCT05028127 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Bimekizumab

Sponsor

UCB Celltech